Clinicopathological implication of cripto expression in early stage invasive cervical carcinomas

Area of Science:

• Oncology
• Molecular Biology
• Gynecologic Pathology

Background:

• Cervical cancer remains a significant global health concern.
• Understanding molecular markers involved in cancer progression is crucial for developing targeted therapies.
• Cripto (CR-1) protein's role in uterine cervical cancer is not fully elucidated.

Purpose of the Study:

• To evaluate the expression of cripto (CR-1) protein in non-neoplastic cervical epithelium, primary cervical carcinoma, and metastatic lymph nodes.
• To investigate the association between CR-1 expression and clinicopathological prognostic variables in early-stage cervical carcinomas.
• To determine the potential role of CR-1 in the development and progression of uterine cervical cancer.

Main Methods:

• Analysis of 94 primary cervical carcinomas with matched non-neoplastic epithelium and lymph node samples.
• Immunohistochemical assessment of CR-1 protein expression.
• Comparison of CR-1 immunoreactivity with clinicopathological variables including tumor grade, size, invasion depth, and metastasis status.

Main Results:

• Strong CR-1 immunopositivity significantly correlated with increased tumor size and lymphovascular space involvement.
• CR-1 expression showed a significant relationship with endometrial extension and parametrial involvement.
• CR-1 levels were notably higher in metastatic lymph nodes compared to primary tumors.

Conclusions:

• CR-1 protein expression is upregulated in cervical carcinoma and associated with adverse prognostic factors.
• Elevated CR-1 in metastatic lymph nodes indicates its potential role in promoting cancer spread.
• CR-1 may serve as a potential biomarker for cervical cancer progression and warrants further investigation.